Global pharmaceutical company: Increasing the speed and quality of the drug discovery pipeline

Find out how a global pharmaceutical company increased the net present value to $22.8 million in over 3 years; 10 months to break-even with CDP Private Cloud investment. This company also reduced time for genome-wide association studies analysis from 80 years to a few weeks. 97% of data is visible to users within R&D. See how this improved success rate for drug development process through predictive analytics resulted in a massive impact for their ogranisation.